|
Volume 271, Number 51,
Issue of December 20, 1996
pp. 33131-33140
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Biochemical Studies of Saccharomyces cerevisiae
Myristoyl-coenzyme A:Protein N-Myristoyltransferase
Mutants*
(Received for publication, June 5, 1996, and in revised form, September 5, 1996)
Litao
Zhang
,
Emily
Jackson-Machelski
and
Jeffrey I.
Gordon
From the Department of Molecular Biology and Pharmacology,
Washington University School of Medicine,
St. Louis, Missouri 63110
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES
ABSTRACT
Saccharomyces cerevisiae
myristoyl-CoA:protein N-myristoyltransferase (Nmt1p)
is an essential 455-residue, monomeric enzyme that catalyzes the
transfer of myristate from myristoyl-CoA to the
NH2-terminal Gly residue of cellular proteins. Nmt1p has an ordered Bi Bi reaction mechanism with binding of myristoyl-CoA occurring before binding of peptide substrates. To define residues important for function, the polymerase chain reaction was used to
generate random mutations in the NMT1 gene. A colony color sectoring assay was used to screen a library of 52,000 transformants for nmt1 alleles encoding enzymes with reduced activity.
nmt1 alleles were identified that produced
temperature-sensitive (ts) growth arrest due to substitutions affecting
eight residues conserved in orthologous Nmts: Asn102,
Ala202, Cys217, Ser328,
Val395, Asn404, Leu420, and
Asn426. Ala202 Thr, Cys217 Arg, Ser328 Pro, Asn404 Tyr, and
Asn426 Ile produced the most severe ts phenotype. Their
effects on the functional properties of the enzyme's myristoyl-CoA and
peptide binding sites were defined by purifying each mutant from
Escherichia coli and conducting in vitro
kinetic analyses with acyl-CoA and peptide substrates and with
two competitive inhibitors: S-(2-oxo)pentadecyl-CoA, a
nonhydrolyzable myristoyl-CoA analog, and SC-58272, a peptidomimetic derived from the NH2-terminal sequence of an Nmt1p
substrate (ADP-ribosylation factor-2, Arf2p). None of the substitutions
affect the enzyme's acyl chain length selectivity. When compared with
wild type Nmt1p, Cys217 Arg produces 3- and 6-fold
increases in Ki for SC-58272 at 24 and 37 °C but
no change in Ki for
S-(2-oxo)pentadecyl-CoA, indicating that the substitution
selectively affects Nmt1p's peptide binding site. Asn426
Ile selectively perturbs the myristoyl-CoA binding site, resulting in the most pronounced reduction in affinity for
S-(2-oxo)pentadecyl-CoA (12- and 20-fold).
Ala202 Thr, which confers the most severe ts phenotype,
provides an example of a substitution that affects both sites,
producing 3- and 6-fold increases in the Ki for
S-(2-oxo)pentadecyl-CoA and 6- and 9-fold increases in the
Ki for SC-58272 at 24 and 37 °C. An
N-myristoylation-dependent change in the
electrophoretic mobility of Arf1p was used to assay the effects of the
mutants on cellular levels of protein N-myristoylation
under a variety of growth conditions. The ts growth arrest produced by
nmt1 alleles correlates with a reduction in myristoyl-Arf1p
to 50% of total cellular Arf1p.
INTRODUCTION
Myristoyl-CoA:protein N-myristoyltransferase
(Nmt1, EC 2.1.3.97) catalyzes the
co-translational, covalent attachment of myristate (C14:0) to the
NH2-terminal glycine of eukaryotic cellular and viral
proteins (1). Nmt is a potential target for antiviral (2, 3, 4),
antifungal (5, 6, 7), and antineoplastic therapy (8, 9, 10).
Saccharomyces cerevisiae Nmt1p has been used as a model for
examining the enzyme's kinetic mechanism, substrate specificities, and
biological functions. The NMT1 gene is essential for
vegetative growth (11, 12). It encodes a 455-residue cytoplasmic
protein (13). Nmt1p has no known co-factor requirements (14). The enzyme's mechanism is ordered Bi Bi (15). Apoenzyme binds
myristoyl-CoA, forming a high affinity myristoyl-CoA·Nmt1p complex
(Kd = 15 nM; Ref. 16). There is
heterotropic cooperativity between the enzyme's acyl-CoA and peptide
binding sites; formation of the binary complex allows synthesis of a
peptide binding site (16). After assembly of a ternary
myristoyl-CoA·Nmt1p·peptide complex, C14:0 is transferred from CoA
to the peptide substrate, and the products are released (CoA followed
by myristoylpeptide). Nmt1p's acyl-CoA and peptide specificities have
been defined in vitro using purified enzyme, >300 fatty
acid analogs with systematic alterations in chain length, polarity,
conformation, and steric bulk, plus >100 octapeptides representing
variations in the NH2-terminal sequences of known
N-myristoylproteins (reviewed in Ref. 1).
The primary structures of six orthologous Nmts have been determined
(11, 17, 18, 19). The 450-529-residue proteins contain 105 absolutely
conserved amino acids. Searches of current protein data bases with
these primary structures has failed to disclose any discernible
homology to other sequence entries.
Only a modest amount of information exists about Nmt1p's
structure/activity relationships. Deletion analyses suggest that the
minimal domain required for myristoyltransferase activity spans
Ile59-Phe96 through
Gly451-Leu455 (20). Two distinct genetic
selections have identified two residues important for function. An
allele with a single amino acid substitution, Gly451 Asp (nmt1-451D) was recovered during a screen for mutations that cause temperature-sensitive (ts) fatty acid auxotrophy (12, 21).
nmt1-451D produces growth arrest at various stages of the cell cycle 1 h after shifting from 24 to 37 °C and produces
lethality after an 8-12-h incubation at nonpermissive temperatures
(12, 22). The growth arrest and lethality can be rescued at 37 °C by
adding myristate but not shorter or longer chain saturated fatty acids.
Another allele with a single Leu99 Pro substitution
(nmt1-99P) is associated with undermyristoylation of Gpa1p,
thereby reducing this subunit's affinity for the  polypeptides of a heterotrimeric G protein involved in the mating response (23, 24). The resulting free  subunits produce constitutive activation of the mating pathway and growth arrest. Leu99 Pro results in less global alterations in protein
N-myristoylation than does Gly451 Asp (24).
Gly451 and Leu99 are conserved in all six known
Nmts. Introduction of the Gly Asp substitution in
Cryptococcus neoformans and Candida albicans Nmts
also produces temperature-sensitive growth arrest and myristic acid
auxotrophy in these fungal pathogens (5, 6).
Site-directed mutagenesis has been used to replace each of human Nmt's
four conserved His residues with Asn and each of its two conserved Cys
residues with Ser (25). Site-directed mutagenesis of absolutely
conserved amino acids can be very useful for identifying residues
critical for substrate recognition, binding, and/or catalysis. In the
case of Nmt, designing such experiments is hindered by the high
percentage of conserved amino acids, by the lack of homology to other
proteins, and by the lack of a rapid screening assay for disabling
mutations. In this report, we describe how random PCR mutagenesis and
an in vivo screen can be used to recognize mutations of
conserved residues in Nmt1p that affect the functional properties of
its myristoyl-CoA and/or peptide binding sites.
EXPERIMENTAL PROCEDURES
Yeast Strains and Media
pBB110 is a 2 µ YEp plasmid containing NMT1 (11).
The isogenic strains YB332 (MATa NMT1 ura3-52
his3 200 ade2-101 lys2-801 leu2-3,112) and YB336
(MATa nmt1-181 ura3-52 his3 200 ade2-101
lys2-801 leu2-3,112) were described by Johnson et al. (24). YB510 (MAT nmt1::HIS3 ura3-52 his3 200
ade2-101 ade3 lys2-801 leu2-3,112 trp1 901, pBB110) was
obtained from a cross between YB133 (MATa
nmt1::HIS3 ura3-52 his3 200 ade2-101 lys2-801 trp1 901
can1 leu2::pRY181, pBB110) and YB428 (MAT
nmt1-181 ura3-52 his3 200 ade2-101 ade3 leu2 trp1 901).
YB523 was obtained from YB510 by replacing pBB110 with pBB290, a high
copy 2 µ NMT1 ADE3 URA3 plasmid derived from pTSV31A
(kindly supplied by Alan Bender, Indiana University).
Strains were incubated at 24-40 °C on YPD (1% yeast extract, 2%
peptone, 2% dextrose)/agar plates with or without myristate (500 µM; NuChek-Prep). Brij 58 (1% (w/v);
Sigma) was included in media containing myristate.
Synthetic complete medium (SC) minus leucine and/or uracil (BIO 101)
was used for selection of plasmids with LEU2 and
URA3 markers. Episomes with URA3 were removed from cells by plating them on SC supplemented with 0.1%
5-fluoro-orotic acid (5-FOA; PCR, Inc.).
Random PCR Mutagenesis and Colony Color Sectoring Assay
The entire open reading frame (ORF) of NMT1 plus
three overlapping subdomains of the ORF were amplified by PCR (Fig.
1A). PCR was performed using the conditions described in
Fig. 1B plus the following thermocycling protocol: 94 °C
for 1 min (denaturation), 55 °C for 2 min (annealing), and 72 °C
for 3 min (extension) for a total of 30 cycles.
Fig. 1.
Summary of PCR mutagenesis of
NMT1. A, the locations of unique restriction
sites in the NMT1 ORF are shown at the top. Primers A-E were used for amplifying all or portions of NMT1
in eight separate polymerase chain reactions. Regions of
NMT1 were replaced by the portions of the PCR products
highlighted by shadowed boxes. Replacement was accomplished
by co-transformation of S. cerevisiae with the PCR fragment
and a gapped plasmid with homology to both ends of the fragment
(homology regions are indicated by lines flanking the
shadowed boxes). In vivo recombination repaired the gap with the PCR fragment (see Fig. 2). B, summary of
phenotypic analysis of transformants.
[View Larger Version of this Image (29K GIF file)]
Each PCR fragment was used to replace a segment of the NMT1
ORF by in vivo recombination with a gapped plasmid
(26). Replacement involved the following steps: (i) the PCR product was
purified by agarose gel electrophoresis and the GeneClean kit (BIO
101); (ii) pBB361 (NMT1 LEU2) was digested with either
NcoI and BalI, NcoI and
AvrII, SphI and MluI, or
BalI alone (Fig. 1A), and the linearized, gapped
plasmids were purified as in the first step; (iii) S. cerevisiae strain YB523 (nmt1 , ura3-52,
ade2, ade3, leu2, pBB290) was co-transformed with the PCR
fragment and gapped plasmids (27); (iv) cells were plated on SC minus
leucine and incubated for 3 days at 30 °C.
A colony color sectoring assay was performed as outlined in Fig. 2.
Leucine prototrophs were replated on YPD and incubated at 30 °C for
5 days. Individual red colonies were restreaked on YPD and incubated
for 5 days at 30 °C. Colonies that continued to exhibit a
nonsectoring (red) phenotype due to retention of the 2 µ pBB290
episome (NMT1 ADE3 URA3), were replica plated onto SC/5-FOA
minus leucine and incubated at 24 °C and 35-40 °C to identify
nmt1 mutations that produced a ts growth phenotype.
Fig. 2.
Colony color sectoring assay used to identify
nmt1 mutants with altered functional properties.
ADE2, 5-phosphoaminoimidazole-ribose carboxylase;
ADE3, C1-5,6,7,8-tetrahydrofolate synthase;
CEN, centromeric sequence; KanR,
kanamycin resistance gene. See "Experimental Procedures" for further discussion.
[View Larger Version of this Image (22K GIF file)]
Total cellular nucleic acids were extracted (28) from ts isolates and
used to transform Escherichia coli strain JS5. Plasmids were
purified from bacterial colonies that grew on Luria broth (LB)
supplemented with kanamycin (50 µg/ml). The nucleotide sequence of
each plasmid's nmt1 insert was determined using a panel of 14 oligonucleotide primers (11, 12), a DyeDeoxy terminator cycle
sequencing kit, and a model 373 Automated DNA Sequencer (Applied
Biosystems). The primers cover both strands of NMT1's ORF
at intervals of 200 base pairs. 400-500 base pairs of sequence were
obtained per primer, allowing 200-300-base pair overlaps between each
primer-driven reaction.
Site-directed Mutagenesis
Twenty-three of the ts nmt1 alleles contained more
than one amino acid substitution. These multiply mutated protein
sequences were aligned with one another and with the sequences of
orthologous Nmts using the algorithm included in GeneWorks (version
2.4). The alignments identified eight residues that were conserved in five or six of the six known Nmts and mutated in the ts nmt1
alleles. Site-directed mutagenesis was used to introduce each of
the eight mutations (individually) into NMT1's ORF:
Asn102 Thr (AAC ACC); Leu171 Ser
(TTG TCG); Lys389 Ile (AAA ATA);
Val395 Asp (GTT GAT); Leu408 Ser
(TTG TCG); Phe413 Ser (TTC TCC);
Asp417 Val (GAC GTC); and Leu420 Ser (TTG TCG). The entire ORF of each site-directed mutant nmt1 allele was sequenced to confirm that only the desired
nucleotide substitution was present.
Measurement of Steady-state Levels of Wild Type and Mutant
Nmts in S. cerevisiae
pBB290 (see above) was removed from strain YB523
(nmt1 ) and replaced (29) with low copy centromeric
pRS315-derived plasmids (30) that contained a
LEU2-selectable marker, kanamycin and ampicillin resistance
genes, and a mutant nmt1 ORF under the control of the
NMT1 promoter (31). These plasmids include pBB391
(nmt1-102T); pBB387 (nmt1-202T); pBB386
(nmt1-217R); pBB380 (nmt1-328P); pBB392 (nmt1-395D); pBB381 (nmt1-404Y); pBB393
(nmt1-420S); pBB385 (nmt1-426I); pBB382
(nmt1-451D); and an NMT1 control (pBB361).
One hundred-milliliter cultures of the various transformants were grown
at 24 °C in YPD to an A600 = 0.8. Twenty-five-milliliter aliquots were removed and incubated at 24 or
37 °C for 2 h. Cells were subsequently harvested by
centrifugation at 1,600 × g for 10 min at 4 °C and
washed twice with 15 ml of phosphate-buffered saline. The cell pellet
was resuspended in 0.5 ml of lysis buffer (2% SDS, 80 mM
Tris, pH 6.8, 200 µM Pefabloc SC, 2 µM
leupeptin, 2 µM pepstatin; all protease inhibitors from
Boehringer Mannheim). Cells were disrupted by vortexing with 0.5 ml of
425-600-µm glass beads (Sigma; vortexing was in
four cycles, 1 min/cycle). The mixture was boiled for 10 min. Cellular
debris were removed by centrifugation at 10,000 × g
for 5 min. The protein concentration in the cleared lysates was
determined using the BCA assay kit (Pierce). Equal masses of protein
from each sample (100 µg) were reduced, denatured, fractionated by
SDS-PAGE (32), and transferred to polyvinylidene difluoride membranes
(Amersham Corp.). Western blots were probed with a previously
characterized rabbit anti-C. albicans Nmt sera that
recognizes the orthologous S. cerevisiae acyltransferase
(Ref. 19; diluted 1:5000 in Blotto). Antigen-antibody complexes were
visualized using an enhanced chemiluminescence (ECL) kit and the
protocol recommended by its manufacturer (Amersham).
Purification of Nmts from E. coli
Generation of Bacterial Expression Vectors Encoding
Polyhistidine-tagged Wild Type and Mutant Nmts
pBB376
(kindly supplied by Jennifer Lodge, Washington University) was
derived from pMON22310 (origin of replication, pBR322; selectable
marker, streptomycin resistance gene). pBB376 contains the NMT1
ORF with an NH2-terminal tag of six histidine residues (6XHis). Expression of 6XHis-Nmt1p is controlled by the
isopropyl- -D-thiogalactopyranoside-inducible Ptac
promoter. Appropriate restriction enzymes were used to place a fragment
of an nmt1 ORF containing an amino acid substitution into
similarly digested pBB376, yielding the following plasmids: pBB390
(6XHis-nmt202Tp); pBB389 (6XHis-nmt217Rp); pBB378 (6XHis-nmt328Pp); pBB379 (6XHis-nmt404Yp); pBB388 (6Xhis-nmt426Ip); and pBB377
(6XHis-nmt451Dp). The ORFs contained in each 6XHis-nmt1p expression
vector were sequenced on both strands to verify that no additional
nucleotide changes had been introduced during vector construction.
Expression and Purification of 6XHis-Nmts
1.5-liter
cultures of E. coli strain JM101, containing a 6XHis-nmt1p
expression plasmid, were grown in LB/streptomycin (30 µg/ml) and 100 µM isopropyl- -D-thiogalactopyranoside at
24 °C for ~12 h until they reached an A600 = 1. Bacteria were harvested by centrifugation at 5,000 × g for 20 min at 4 °C and resuspended in 50 ml of buffer A
(0.3 M NaCl, 5 mM -mercaptoethanol, 1 mM Pefabloc SC, 2 µM leupeptin, 2 µM pepstatin, 25 mM sodium phosphate buffer,
pH 7.0). Cells were lysed with French press at 3,200 p.s.i. The lysates
were centrifuged at 20,000 × g for 30 min at 4 °C. Each supernatant was collected and mixed with 5 ml of
Ni2+-NTA-agarose (Qiagen; the resin was washed three times
with buffer A before use). The resulting suspension was incubated on
ice for 2 h with intermittent shaking and then subjected to
centrifugation at 3,000 × g for 5 min at 4 °C. The
supernatant was removed and discarded. The Ni2+-NTA-agarose
was washed four times with ice-cold buffer A (30 ml/wash) and loaded
into an empty 10-ml Poly-Prep column (Bio-Rad). The column was washed
with 10 ml of buffer A containing 40 mM imidazole. Nmt
activity was eluted by sequentially washing the column with 3 ml of
buffer A containing 60 mM, 80 mM, 100 mM, 120 mM, and finally 150 mM
imidazole. Wild type and mutant enzymes eluted with buffer A, 120 mM imidazole and were used on the day of their purification
for kinetic studies (see below). Wild type 6XHis-Nmt1p and each mutant
6XHis-nmt1p were purified on at least three separate occasions. The
purity of each preparation was verified by SDS-PAGE followed by
Coomassie staining.
Nmt1p without an NH2-terminal 6XHis tag was also expressed
in E. coli and purified to apparent homogeneity using a
protocol described by Rudnick et al. (33).
Kinetic Studies of Wild Type and Mutant Nmts
Assessment of Peptide Substrate Specificity
A coupled
in vitro Nmt assay system was employed (33, 34).
[3H]Myristoyl-CoA was generated first using
[3H]myristate, CoA, and Pseudomonas acyl-CoA
synthetase (Boehringer Mannheim). A purified wild type or mutant Nmt
was then added together with a peptide substrate. Following a 10-min
incubation at 24 or 37 °C, [3H]myristoylpeptide was
purified from the reaction mixture by reverse phase high pressure
liquid chromatography using a 4.6 µm (internal diameter) × 150-mm C4
column (Vydac) and a linear gradient from H2O containing
0.1% trifluoroacetic acid and 0.05% triethylamine to acetonitrile,
0.1% trifluoroacetic acid. The amount of
[3H]myristoylpeptide produced was quantitated with an
in-line scintillation counter (Packard).
The peptide substrate specificities of Nmt1p, 6XHis-Nmt1p, and each
mutant 6XHis-nmt1p were compared at 24 and 37 °C using a panel of
five previously defined octapeptide substrates of Nmt1p. Each
octapeptide was assayed at a final concentration of 90 µM in the presence of 230 nM [3H]myristoyl-CoA
and 0.1-250 µg/ml acyltransferase. The panel was composed of
GNSSSKSS-NH2 (NH2-terminal sequence of S. cerevisiae Ppz1p), GNSGSKQH-NH2 (Ppz2p),
GAAPSKIV-NH2 (Cnb1p), GNAAAARR-NH2 (bovine C
subunit of protein kinase A), and GARASVLS-NH2 (human immunodeficiency virus I Pr55gag).
Determination of the Km and Vmax of Known
Octapeptide Substrates
Peptide kinetics were determined at 24 and
37 °C using 100 ng/ml of Nmt1p, 1-250 µg/ml of 6XHis-Nmt1p or a
mutant 6XHis-nmt1p, 230 nM [3H]myristoyl-CoA,
and GNSGSKQH-NH2 (0.1-20 µM) or
GAAPSKIV-NH2 (0.01-4 µM). Peptide
Km and Vmax were calculated
using double reciprocal plots.
Defining the Affinity of Mutant Nmts for a Peptidomimetic
Inhibitor, SC-58272
A series of Km values
were defined for the Ppz2p octapeptide substrate (10-20
µM) at 24 and 37 °C using 230 nM
[3H]myristoyl-CoA, 10-1000 nM of the
peptidomimetic inhibitor SC-58272 (7), and 0.1-250 µg/ml of Nmt1p,
6XHis-Nmt1p, or a 6XHis-nmt1p. The Km at each
inhibitor concentration and the type of inhibition were determined
using double reciprocal plots. A Ki was obtained
from a plot of the Km values versus the
inhibitor concentration.
Assessment of Acyl-CoA Substrate Specificity
The acyl chain
length selectivities of Nmt1p, 6XHis-Nmt1p, and each 6XHis-nmt1p were
compared at 24 and 37 °C using C12:0-CoA, C14:0-CoA, and C16:0-CoA
(final concentration = 18 µM) and
GAR[3H]ASVLS-NH2 (Ref 34; specific
activity = 373 mCi/mmol, final concentration = 25 µM).
Defining the Affinity of Wild Type and Mutant Nmts for a
Nonhydrolyzable Myristoyl-CoA Analog, S-(2-Oxo)pentadecyl-CoA
A
series of myristoyl-CoA Km values were determined
at 24 and 37 °C using [3H]myristoyl-CoA (0.2-10
µM), the Ppz2p octapeptide (10-20 µM), varying amounts of the competitive inhibitor
S-(2-oxo)pentadecyl-CoA (0.005-1 µM), and
purified Nmt1p, 6XHis-Nmt1p, or a 6XHis-nmt1p. The
Km at each inhibitor concentration and type of
inhibition were determined using double reciprocal plots.
Ki values were calculated from a plot of
Km versus the inhibitor concentration.
General Comments about the Kinetic Analyses
Each
6XHis-tagged enzyme preparation was studied at each temperature using
purified Nmt1p without a 6XHis tag as a reference control. Analysis of
myristoylpeptide production by the Nmts at 24 and 37 °C indicated
that the enzymes were stable over the course of the 10-min incubation
period. The kinetic studies involved over 3,000 datapoints, each
obtained either in duplicate or triplicate. The mean percentage
difference between duplicate datapoints was 9.9 ± 9.4 (S.D.). The
mean percentage difference between triplicate datapoints was 12.8 ± 11.6.
Gel Mobility Shift Assay for Assessing the Degree of
N-Myristoylation of Arf1p in Strains Containing Wild Type or Mutant
Nmts
pBB290 in YB523 (nmt1 ) was replaced with low copy
centromeric pRS315-based plasmids containing NMT1 or one of
the ts nmt1 alleles. One hundred-milliliter cultures of the
various strains were grown at 24 °C in YPD to an
A600 = 0.8. Twenty-five-milliliter aliquots were
removed and incubated at 24 or 37 °C for 2 h. Cell lysates were
prepared using the same protocol employed for measurement of
steady-state Nmt levels. Western blots were probed with rabbit antiserum R23 raised against a peptide (SNSLKNST) encompassing the
C-terminal eight residues of Arf1p (kindly supplied by Richard Kahn,
Emory University; final dilution = 1:2000 in Blotto. Note that R23
does not cross-react with Arf2p, whose C-terminal sequence is
SNNLKNQS).2 Antigen-antibody complexes were
visualized as described above.
RESULTS AND DISCUSSION
Random PCR Mutagenesis and a Colony Color Sectoring Assay Yields a
Series of nmt1 Alleles Encoding Temperature-sensitive Mutants
Specific regions of NMT1 were targeted for random
mutagenesis using in vivo recombination to repair a gapped
plasmid with PCR fragments (Figs. 1 and
2). A colony color sectoring assay (35, 36) was used to
identify nmt1 alleles encoding mutant enzymes with reduced
activity. This assay (Fig. 2) takes advantage of the fact that two
mutations within the S. cerevisiae purine nucleotide
biosynthetic pathway, when present in different combinations, give rise
to colonies with different colors. Mutations in ADE2 cause
accumulation of the chromophore phosphoribosylaminoimidazole, resulting
in red colonies. Strains with ADE3 mutations do not accumulate the chromophore and grow as white colonies. ADE3
mutations also affect an enzymatic step upstream of Ade2p.
Therefore, ade2 ade3 strains grow as white colonies.
Introduction of a low copy centromeric plasmid containing NMT1
and ADE3 into an ade2 ade3 nmt1 strain
produces cells that form red colonies (Fig. 2). Since NMT1
is essential, if these cells lose this plasmid they die. Viable
colonies containing the episomal copy of NMT1 and
ADE3 remain red. If a second episome is introduced
containing products from the PCR mutagenesis, one of two color
phenotypes will be observed. If the mutation does not reduce Nmt1p's
activity below the point required to acylate essential cellular
N-myristoylproteins at levels compatible with viability,
then there will be no selective pressure to retain the plasmid;
i.e. during the course of cell division, 5-20% of newly
formed daughter cells will lose the NMT1 ADE3 plasmid, and
colonies will appear as red circles containing white sectors (sectoring
phenotype). If a mutation inactivates NMT1, then the colony
will be forced to retain the NMT1 ADE3 plasmid and will
remain red (nonsectoring phenotype). Replica plating nonsectoring red
colonies onto 5-FOA-containing plates will force the nmt1 ade2
ade3 leu2 host strain to remove the URA3-containing NMT1 ADE3 episome, thereby revealing the phenotype produced
by the remaining LEU2 episome with its mutant nmt1
allele (Fig. 2).
Three overlapping regions of NMT1's ORF (Met1
Leu345, Ala202 Asn397, and
Lys389 Leu455) or the entire ORF were
replaced by DNA fragments generated using standard conditions for the
polymerase chain reaction or conditions designed to increase the error
rate of Taq polymerase. A total of 52,000 transformants were
screened; 2122 transformants (4%) had a nonsectoring phenotype, 1093 of the nonsectoring colonies (51%) had a lethal phenotype when
incubated at 24 °C on synthetic complete media containing 5-FOA but
lacking leucine, and 35 nonsectoring colonies had a ts phenotype based
on differences in their growth in this media at 24 and 35 or 40 °C
(Fig. 1B).
Polymerase chain reactions 1-3, performed under standard conditions,
produced 47 nonsectoring transformants with a lethal phenotype and two
with a ts phenotype (Fig. 1, A and B). Plasmids were recovered from 38 of the transformants with a lethal phenotype: 25 of the 38 did not contain any NMT1 sequences and presumably arose from self-ligation of the gapped plasmids. Sequence analysis of
the remaining 13 plasmids revealed that they encoded truncated enzymes.
Nine contained insertions or deletions that produced frameshifts,
resulting in the introduction of three to nine amino acid substitutions
followed by a stop at Val214, Val310,
Leu398, Lys399, Ser400,
Leu411, or Leu420; four contained single base
changes that produced a stop codon at Glu317,
Ser331, Gln402, and Leu406. The two
plasmids that produced a ts phenotype contained nmt1 alleles
with single amino acid substitutions affecting conserved residues:
Ser328 Pro (nmt1-328P) and
Asn404 Tyr (nmt1-404Y ) (Fig.
3, A and B).
Fig. 3.
Mutations that produce ts nmt1
alleles. A, summary of nucleotide and amino acid
substitutions. B, alignment of six orthologous Nmts.
Absolutely conserved residues are boxed. Amino acid
substitutions that produce ts growth arrest in S. cerevisiae are indicated by residue number and the substituted amino acid (e.g. 102T = Asn102 Thr). The C. elegans Nmt sequence was defined from a cDNA recovered from a
Bristol N2 strain library. The protein product was expressed in, and
purified from, E. coli and found to have Nmt activity (E. Anderson, J. Lodge, E. Jackson-Machelski, and J. Gordon, unpublished observations).
[View Larger Version of this Image (89K GIF file)]
The number of nonsectoring ts colonies obtained with a given set of
primers was affected by the PCR conditions employed and by the size of
the region of NMT1 targeted for replacement by in vivo
repair of the gapped plasmid. Manipulating these two parameters (reactions 4-8 in Fig. 1B) yielded 33 additional plasmids
that conferred a ts phenotype. Three plasmids had nmt1
alleles with single amino acid substitutions affecting absolutely
conserved residues: Ala202 Thr (nmt1-202T
), Cys217 Arg (nmt1-217R), and
Asn426 Ile (nmt1-426I) (Fig. 3,
A and B). Nucleotide sequence analysis of the
remaining plasmids revealed 24 unique nmt1 alleles, all of
which contained multiple amino acid substitutions (range = 2-6
substitutions). A total of 64 amino acids were altered in these 24 alleles. Of these 64 residues, 6 were mutated in at least two different
alleles: Ala202, Lys389, Val395,
Leu408, Asp417, and Asn426. All of
these amino acids are conserved (Fig. 3B). Two of these substitutions, Ala202 Thr and Asn426 Ile, were also represented in other ts nmt1 alleles with
single amino acid changes (see above). Moreover, mutations that
affected four of the six residues did not always result in the same
amino acid substitution: Ala202 was replaced with either
Thr or Gly, Lys389 with Asn or Ile, Val395 with
Asp, Ala, or Gly, and Asp417 with Asn or Val. Together,
these findings suggested that the PCR mutagenesis of NMT1
was comprehensive.
Alignments of the 24 multiply substituted protein sequences with the
six orthologous Nmts revealed a total of 11 substitutions that affected
eight conserved residues. Site-directed mutagenesis was used to
generate eight nmt1 alleles, each containing a single substitution: Asn102 Thr, Leu171 Ser,
Lys389 Ile, Val395 Asp,
Leu408 Ser, Phe413 Ser,
Asp417 Val, and Leu420 Ser (Fig.
3B). (In the three instances where a conserved residue was
replaced by more than one amino acid (Lys389,
Val395, and Asp417), we selected the
replacement that was more frequently encountered in our library of ts
nmt1 alleles.)
The eight nmt1 alleles engineered by site-directed
mutagenesis were tested to determine whether they conferred a ts
phenotype. An nmt1 strain, with a low copy centromeric
plasmid containing NMT1 (wild type control),
nmt1-451D (ts mutant control, see the Introduction), or one
of the eight nmt1 alleles, was incubated at 24, 30, 33, 35, 37, and 40 °C on YPD/agar. The NMT1 episome supported
similar rates of growth over this broad temperature range. An episome
with the previously characterized nmt1-451D allele resulted
in growth arrest at 40 °C. Asn102 Thr
(nmt1-102T), Val395 Asp
(nmt1-395D), and Leu420 Ser
(nmt1-420S) also produced complete growth arrest at
40 °C (Fig. 4A). In contrast, plasmids
containing nmt1 alleles with Leu171 Ser,
Lys389 Ile, Leu408 Ser,
Phe413 Ser, or Asp417 Val substitutions
had no detectable effect on growth, even at 40 °C (data not
shown).
Fig. 4.
Assessing the stability of mutant nmt1ps at
permissive and nonpermissive temperatures. A, equal numbers
of nmt1 cells, transformed with low copy pRS315-based
centromeric plasmids containing the indicated wild type and mutant
NMT1 alleles, were replica-plated onto YPD and incubated for
3 days at the indicated temperatures. The results shown are
representative of those obtained in six independent experiments, each
done in duplicate. B, the strains shown in A were
grown to mid-log phase in YPD at 24 °C and shifted to 37 °C for
2 h. Western blots of cell lysates (100 µg of total protein/lane) were probed with rabbit anti-Nmt sera. Antigen-antibody complexes were visualized using ECL. The position of migration of the
intact 52-kDa N-myristoyltransferase is indicated.
Preincubation of Nmt antibodies with purified Nmt1p blocked their
subsequent reaction with the 52-kDa polypeptide (data not shown). Each
blot was subsequently stripped and reprobed with antibodies to yeast actin. The results (not shown) indicated that each lane contained equal
amounts of actin.
[View Larger Version of this Image (56K GIF file)]
Fig. 4A also shows the phenotypes produced by the five ts
nmt1 alleles obtained directly from the colony color
sectoring screen and found to contain single amino acid substitutions.
Growth arrest occurred at 30 °C (Ala202 Thr,
nmt1-202T), 35 °C (Ser328 Pro,
nmt1-328P, and Asn426 Ile,
nmt1-426I), 37 °C (Asn404 Tyr,
nmt1-404Y) or 39 °C (Cys217 Arg,
nmt1-217R).
The remaining 1046 nonsectoring colonies with lethal phenotypes were
generated by using modified PCR conditions designed to increase the
error rate of Taq polymerase or by targeting the entire
NMT1 ORF. There was no obvious difference in the frequency of nonsectoring colonies with lethal phenotypes when the modified PCR
conditions were used to target Met1 Leu345,
Ala202 Asn397, or Lys389 Leu455 (reactions 4-6 in Fig. 1B). Our analyses
of the 35 nonsectoring colonies with a ts phenotype and the 47 nonsectoring colonies with a lethal phenotype suggested that the
majority of the nmt1 alleles that would be recovered from
these 1046 colonies would contain multiple amino acid substitutions
and/or stop codons. Therefore, they were not analyzed further.
Steady-state Levels of Mutant Nmts at Permissive and Nonpermissive
Temperatures
nmt1 cells, containing episomal copies of one of the
eight ts nmt1 alleles with single amino acid substitutions,
were incubated in YPD broth at the permissive temperature (24 °C)
until they reached mid-log phase. The temperature was then raised to
37-40 °C for 2 h. Western blots of total cellular proteins
were prepared and probed with a previously characterized rabbit
anti-Nmt sera (19). The steady-state levels of six of the mutant
acyltransferases were equivalent to each other and to Nmt1p (Fig.
4B). The concentration of nmt420Sp at 24 °C was equal to
Nmt1p but was 50% that of the wild type enzyme at 37-40 °C.
nmt328Pp was ~3-fold less abundant than Nmt1p at permissive and
nonpermissive temperatures (Fig. 4B). Thus, with the
exception of nmt1-328P and nmt1-420S,
differences in temperature sensitivity produced by the mutant
nmt1 alleles could not be simply ascribed to differences in
the steady-state levels of their protein products.
In Vitro Kinetic Studies of Purified Wild Type and Mutant Nmts
As noted above, five of the eight ts nmt1 alleles
produced growth arrest on YPD at 39 °C. To define the effects of
their Ala202 Thr, Cys217 Arg,
Ser328 Pro, Asn404 Tyr, and
Asn426 Ile substitutions on substrate recognition
and/or catalysis, each mutant was expressed in E. coli, a
bacterium with no endogenous Nmt activity (37). Nmt1p and nmt451Dp were
used as reference controls. A genetically engineered
NH2-terminal tag of six histidine residues (6XHis) allowed
rapid purification of wild type and mutant enzymes by
Ni2+-NTA-agarose affinity chromatography. The purification
protocol produced a 100-1000-fold increase in specific activity over
what was observed in unfractionated bacterial lysates and yielded
apparently homogeneous preparations of each enzyme based on Coomassie
staining of SDS-polyacrylamide gels (data not shown).
Effects of the Amino Acid Substitutions on the Functional
Properties of Nmt's Myristoyl-CoA Binding Site
The acyl chain
length selectivity of each mutant was examined in an in
vitro assay system that used purified enzyme, unlabeled C12:0-CoA,
C14:0-CoA, or C16:0-CoA, and a fixed concentration of an extensively
characterized radiolabeled octapeptide substrate of Nmt1p
(GAR-[3H]ASVLS-NH2; Refs. 34, 38, and 39).
Neither the addition of the 6XHis tag to Nmt1p nor any of the amino
acid substitutions had statistically significant effects on the
specificity of the acyltransferase reaction at 24 or 37 °C (range of
lauroyltransferase activity = 2-15% of myristoyltransferase
activity; palmitoyltransferase activity = 0-8%;
n = 2 independent preparations of each mutant, each
assayed on two separate occasions in triplicate).
Having established that all of the mutants "retained" their
character as myristoyltransferases, we examined the effects of the
amino acid substitutions on the enzyme's affinity for
S-(2-oxo)pentadecyl-CoA (40). The rationale was as follows.
None of the mutants could be purified in sufficient quantity or were
sufficiently stable at 24 or 37 °C to permit thermodynamic analysis
of myristoyl-CoA binding by isothermal titration calorimetry (ITC), as
has been done with wild type apo-Nmt1p (16). For an ordered reaction such as the one catalyzed by Nmt1p, a competitive inhibitor for the
first of the two substrates, obtained at any concentration of the
second substrate, is a dissociation constant for E + I. S-(2-Oxo)pentadecyl-CoA is a competitive Nmt inhibitor
containing a single methylene insertion between the CoA sulfur and the
fatty acid carbonyl carbon of myristoyl-CoA. Determination of its
Ki required less enzyme and could be performed more
rapidly than ITC analysis of myristoyl-CoA binding. Moreover, ITC has
established that purified apo-Nmt1p perceives
S-(2-oxo)pentadecyl-CoA as a close approximation of
myristoyl-CoA: the enthalpy of binding of the nonhydrolyzable inhibitor
( 25.8 kcal/mol) is equivalent to that of myristoyl-CoA ( 24.8
kcal/mol) (Ref. 16).3
The Ki for S-(2-oxo)pentadecyl-CoA was
defined at 24 and 37°C using the purified mutant Nmts, varying
amounts of [3H]myristoyl-CoA, and an Nmt1p substrate
(GNSGSKQH-NH2; Ref. 22) derived from the
NH2-terminal sequence of Ppz2p, a protein phosphatase that
suppresses the cell lysis defect produced by a protein kinase C null
allele (41, 42). The concentration of peptide was 2-100-fold over its
Km for each mutant Nmt (see below).
For Nmt1p, the Ki is 5 nM (Table
I), a value identical to the Kd
obtained from ITC (16). The addition of an NH2-terminal
6XHis tag to Nmt1p has no appreciable effect on its affinity for
S-(2-oxo)pentadecyl-CoA (Ki = 4-7 nM). The Cys217 Arg substitution in
nmt217Rp does not produce any detectable alteration in affinity for the
inhibitor (5 nM at 24 and 37 °C). In contrast,
Asn426 Ile results in the greatest reduction in
affinity, with Ki increases of 12- and 20-fold at 24 and 37 °C (compared with 6XHis-Nmt1p). Asn404 Tyr
produces no change in affinity at 24 °C but a 5-fold reduction at
37 °C (Ki = 21 nM). The other
substitutions result in ~3-fold increases in Ki at
24 °C and 6-8-fold increases at 37 °C (Table I).
Table I.
Inhibition of wild type and mutant Nmts with
S-(2-oxo)pentadecyl-CoA
Ki values were determined using purified enzyme,
S-(2-oxo)pentadecyl-CoA, varying amounts of
[3H]myristoyl-CoA, and an octapeptide substrate derived from
the NH2-terminal sequence of Ppz2p. The averages of duplicate
determinations are shown. Duplicate values reported in Tables I, II, III
varied by <30% (see "Experimental Procedures").
|
Ki
|
| 24 °C |
37 °C
|
|
|
nM
|
| Nmtlp |
5 |
5 |
| 6XHis-Nmtlp |
7 |
4
|
| 6XHis-nmt202Tp |
23 |
24 |
| 6XHis-nmt217Rp |
5 |
5
|
| 6XHis-nmt328Pp |
17 |
32 |
| 6XHis-nmt404Yp |
4 |
21
|
| 6XHis-nmt426Ip |
85 |
79 |
| 6XHis-nmt451Dp |
25 |
30 |
|
Effects of the Amino Acid Substitutions on the Functional
Properties of Nmt's Peptide Binding Site
As noted in the
Introduction, once a binary myristoyl-CoA·Nmt1p complex forms, an
allosteric transition occurs that allows formation of a functional
peptide binding site. Previous in vitro and in
vivo studies using myristic acid analogs have emphasized that
changes in interactions between apo-Nmt1p and its acyl-CoA substrates
can produce changes in the functional characteristics of the enzyme's
peptide binding site (16, 43, 44). Therefore, we surveyed
myristoylpeptide production at 24 and 37 °C using Nmt1p,
6XHis-Nmt1p, each of the five mutants, saturating amounts of
[3H]myristoyl-CoA, and a panel of five octapeptide
substrates. Two of the peptides had been used for defining each
enzyme's acyl chain length selectivity and its affinity for
S-(2-oxo)pentadecyl-CoA (GARASVLS-NH2 from human
immunodeficiency virus type I Pr55gag and
GNSGSKQH-NH2 from Ppz2p, respectively).
The addition of a 6XHis tag to Nmt1p has no demonstrable effect on
peptide specificity as judged by myristoylpeptide production at 24 and
37 °C. When compared with 6XHis-Nmt1p, the specific activity of each
6XHis-nmt1p mutant is reduced at 24 and 37 °C for all peptides
surveyed. For example, in the case of the Ppz2p peptide, the decrease
ranges from 10- to 50-fold at 24 °C and from 15- to 300-fold at
37 °C. The extent of the reduction in specific activity varies
between the mutants and as a function of the peptide substrate.
Two peptides were selected for more detailed kinetic analysis:
GNSGSKQHP-NH2 (Ppz2p) and GAAPSKIV-NH2
(representing the NH2-terminal sequence of Cnb1p, the
N-myristoylated regulatory subunit of yeast Ca2+/calmodulin-dependent phosphoprotein
phosphatase (45, 46)). They were chosen because all of the mutants were
able to generate readily detectable amounts of these myristoylpeptides
at 24 and 37 °C and because Ppz2p had been used when computing
Ki values for
S-(2-oxo)pentadecyl-CoA.
Asn426 Ile, which results in the greatest reduction in
S-(2-oxo)pentadecyl-CoA affinity (12-20-fold), produces
minimal ( 2-fold) changes in Km for either peptide
at either temperature when compared with 6XHis-Nmt1p (Table
II).
Table II.
Summary of peptide kinetics
| Peptide |
6XHis-Nmtlp |
6XHis-nmt202Tp |
6XHis-nmt217Rp |
6XHis-nmt328Pp |
6XHis-nmt404Yp |
6XHis-nmt426Ip
|
|
|
Km
(nM) |
| GNSGSKQH-NH2
(Ppz2p) |
| 24 °C |
200a |
10,000 |
11,100 |
800 |
600 |
300
|
| 37 °C |
400 |
12,500 |
9500 |
400 |
3200 |
400
|
|
|
Vmaxb
|
| 24 °C |
1450 |
1790 |
72 |
3 |
26 |
170
|
| 37 °C |
4600 |
1100 |
82 |
9 |
37 |
147
|
|
|
Km
(nM) |
| GAAPSKIV-NH2
(Cnb1p) |
| 24 °C |
50 |
300 |
400 |
30 |
400 |
100
|
| 37 °C |
60 |
800 |
1800 |
60 |
1000 |
100
|
|
|
Vmaxb
|
| 24 °C |
1000 |
37 |
4 |
3 |
59 |
36
|
| 37 °C |
2570 |
42 |
17 |
7 |
70 |
25 |
|
|
a
All kinetic parameters represent the average of
duplicate determinations (see legend to Table I).
|
|
b
pmol/min/mg enzyme.
|
|
Cys217 Arg, which has no detectable effect on
S-(2-oxo)pentadecyl-CoA affinity, has a marked effect on
peptide Km: 24-56-fold increases for Ppz2p and 8- and 30-fold increases for Cnb1p (Table II).
Asn404 Tyr, which produces the greatest
temperature-dependent change in Ki for
S-(2-oxo)pentadecyl-CoA among the mutants (Table I), is
associated with perturbations in peptide Km that
also worsen with increasing temperature (Table II).
Ala202 Thr, which produces 3-6-fold decreases in
S-(2-oxo)pentadecyl-CoA affinity at 24 and 37 °C, results
in increases in the Km for both peptides. The
increase is more pronounced for the Ppz2p peptide (30-50-fold) than
for the Cnb1p peptide (6-13-fold; Table II). Ser328 Pro, which results in a similar 3-6-fold decrease in affinity for the
nonhydrolyzable analog as Ala202 Thr, has more modest
effects on peptide Km; the Km of
the Ppz2p octapeptide is only increased 2-4-fold, and there is no
significant change for the Cnb1p peptide (Table II).
All of the amino acid substitutions result in decreases in peptide
Vmax. Ser328 Pro produces the
greatest reductions: ~350- and 500-fold for the Cnb1p and Ppz2p
peptides, respectively (Table II).
We selected the two mutants with the greatest increases in peptide
Km (nmt217Rp (Cys Arg) and nmt202Tp (Ala Thr)) for additional analysis. Increases in peptide
Km cannot be used to conclude that there are
decreases in the mutant enzymes' affinities for these substrates. For
an inhibitor of the second substrate of an ordered reaction, the
inhibition constant is a dissociation constant under conditions where
the first substrate is at a saturating level. Therefore, the effects of
these two amino acid substitutions on the functioning of Nmt's peptide
binding site were explored by determining the Ki for
a peptidomimetic inhibitor. SC-58272 was derived from the
NH2-terminal eight residues of a yeast
N-myristoylprotein, ADP-ribosylation factor-2 (Arf2p; Ref
7). Amino acids 1-4 were replaced with a
para-(2-methylimidazole-N-butyl) phenylacetic
acid derivative, amino acids 7 and 8 (Leu-Ser-NH2) were
deleted, and the 2-cyclohexylethyl amide derivative of lysine was used
as the C-terminal residue (see Fig. 5). SC-58272 is
competitive for binding of peptide substrates but not for myristoyl-CoA
(7). ITC has been used to determine that the Kd of
SC-58272 for myristoyl-CoA·Nmt1p binary complexes is 29 nM.3
Fig. 5.
Structure of SC-58272, a dipeptide inhibitor
of Nmt1p.
[View Larger Version of this Image (8K GIF file)]
Table III presents Ki values for
SC-58272 defined in the presence of saturating amounts of
[3H]myristoyl-CoA and varying amounts of the Ppz2p
peptide. With Nmt1p, the Ki at 24 °C was very
similar to the Kd defined calorimetrically (43 versus 29 nM). The addition of a 6XHis tag to
Nmt1p produces <2-fold changes in the Ki at 24 and
37 °C. Ala202 Thr results in Ki
increases of 6- and 9-fold at 24 and 37 °C compared with
6XHis-Nmt1p. Cys217 Arg produces 3- and 6-fold
increases at these two temperatures.
Table III.
Inhibition of wild type and mutant Nmts by the peptidomimetic
SC-58272
The Ki for SC58272 was defined using purified Nmts,
saturating amounts of [3H]myristoyl-CoA, and varying amounts
of the Ppz2p octapeptide substrate (see "Experimental Procedures").
The averages of duplicate determinations are presented (see legend to
Table I).
|
Ki
|
| 24 °C |
37 °C
|
|
|
nM
|
| Nmtlp |
43 |
14 |
| 6XHis-Nmtlp |
24 |
9
|
| 6XHis-nmt202Tp |
138 |
82
|
| 6XHis-nmt217Rp |
74 |
55 |
|
Conclusions from the Kinetic Studies
The finding that
Cys217 Arg produces an increase in the
Ki for SC-58272 but no change in the
Ki for S-(2-oxo)pentadecyl-CoA indicates
that this substitution of a conserved Cys has selective effects on the
functional properties of the enzyme's peptide binding site. In
contrast, substitution of the conserved Asn426 with Ile
appears to selectively affect the functional properties of the
enzyme's myristoyl-CoA binding site. Ala202 Thr, which
produces the most severe ts phenotype, provides an example of a
substitution that affects the functional properties of both sites,
resulting in increases the Ki for
S-(2-oxo)pentadecyl-CoA and SC-58272. Such a substitution
may perturb specific contacts between the enzyme and the myristoyl or
CoA moieties, which, in turn, could disturb the subsequent allosteric
transition required for creation of a fully functional peptide binding
site. Alternatively, Ala202 Thr may produce more global
changes in the conformation of Nmt1p.
Defining Levels of Acylation of an N-Myristoylprotein in NMT1 and
nmt1 Cells
At 37 °C, adding 500 µM myristate to YPD
media rescues growth of all but one of the ts nmt1 mutants
(data not shown). (nmt1-328P is the exception. Recall that
at 37 °C nmt328Pp has the lowest steady-state cellular concentration
among the mutants (Fig. 4B), the greatest reduction in
peptide Vmax in vitro (Table II), and a 6-fold decrease in affinity for the myristoyl-CoA analog.)
At 39-40 °C, adding 500 µM myristate to YPD only
partially rescues nmt1 cells with nmt1-426I
(lowest affinity for S-(2-oxo)pentadecyl-CoA among the
mutants), nmt1-202T (lowest affinity for SC-58272 plus moderate reductions in affinity for
S-(2-oxo)pentadecyl-CoA), or nmt1-404Y (most
marked change in S-(2-oxo)pentadecyl-CoA affinity between 24 and 37 °C).
Levels of cellular protein N-myristoylation produced by the
wild type and mutant nmt1 alleles were defined under these
various growth conditions using an Arf gel mobility shift assay. Arf1p and Arf2p are two functionally interchangeable but essential
N-myristoylproteins involved in vesicular trafficking (47,
48). They depend upon N-myristoylation for expression of
their biological functions (49). Arf1p represents ~90% of cellular
Arfs (47). N-Myristoylation produces a change in the
electrophoretic mobility of Arf1p during SDS-PAGE; the acylated species
migrates more rapidly than the nonmyristoylated species (19). We
therefore reasoned that Arf1p could be used to report the extent of
cellular protein N-myristoylation by noting the ratio of its
distinctively migrating N-myristoylated and nonmyristoylated
forms.
nmt1 cells containing plasmids with NMT1 or ts
nmt1 inserts were grown in YPD at 24 °C to mid-log phase.
Aliquots of the cultures were then incubated for an additional 2 h
at 24 °C or 33-40 °C in YPD alone or in YPD plus 500 µM myristate. Western blots of total cellular proteins
were prepared and probed with rabbit antibodies that react with Arf1p
but not Arf2p,2 and the ratio of N-myristoylated
to nonmyristoylated Arf1p was determined. Fig. 6 shows
representative results obtained with NMT1,
nmt1-404Y, and nmt328P. Only myristoyl-Arf1p is
detectable in NMT1 cells, whether they are cultured in YPD
at 24, 37, or 40 °C. Defects in protein N-myristoylation
are evident in nmt1-404Y cells when cultured in YPD alone.
Even at the permissive temperature of 24 °C, only ~60% of Arf1p
is acylated; at 37 °C, the value falls below 50%. In
nmt1-328P cells, >95% of Arf1p is
N-myristoylated when grown at 24 °C on YPD; however,
between 33 and 37 °C, myristoyl-Arf1p decreases to 40% of total
Arf1p. The ability of myristate to increase levels of
myristoyl-Arf1p to 50% of total cellular Arf1p can be directly
correlated with its ability to rescue the growth of a given
nmt1 strain. At 37 °C, myristoyl-Arf1p levels increase in
nmt1-404Y cells from <50% to >95% 2 h after
exposure to myristate (Fig. 6). These cells are able to sustain growth
in this media at this temperature. In contrast, myristate has no
detectable beneficial effects on the efficiency of Arf1p acylation in
nmt1-328P cells at 37 °C (Fig. 6), a temperature where
they are unable to survive on YPD/myristate. The gel shift assay was
used to establish that a reduction in levels of myristoyl-Arf1p to
50% is also associated with a failure of cells containing the other
ts nmt1 alleles to survive (data not shown).
Fig. 6.
Gel shift assay for determining the extent of
Arf1p N-myristoylation in nmt1 cells
containing NMT1, nmt1-328P, and
nmt1-404Y episomes. Strains were grown at 24 °C in
YPD until they reached an A600 of 0.8. The
culture was divided into aliquots, which were then incubated at the
indicated temperatures for an additional 2 h in YPD or in YPD plus
500 µM myristate. Total cellular proteins (100 µg of
protein/lane) were fractionated by SDS-PAGE. Western blots were
prepared and probed with a rabbit anti-Arf1p sera. The results shown
are representative of those obtained in three independent
experiments.
[View Larger Version of this Image (40K GIF file)]
Prospectus
A panel of mutant Nmts, with defined defects in the
functioning of their myristoyl-CoA and/or peptide binding sites has
been generated using an error-prone PCR strategy. A full understanding of the structural significance of their amino acid substitutions must
await determination of the atomic structure of Nmt1p with and without
bound substrates or substrate analogs. Nonetheless, the
temperature-sensitive growth arrest produced by various members of this
panel offers an opportunity to conduct genetic screens for factors that
affect Nmt activity, to examine the adaptive responses of cells to
undermyristoylation of cellular proteins, and to identify the functions
of cellular N-myristoylproteins in dividing and nondividing
yeast cells.
FOOTNOTES
*
This work was supported by grants from the National
Institutes of Health (AI38200) and Monsanto. The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Molecular
Biology and Pharmacology, Box 8103, Washington University School of
Medicine, 660 S. Euclid Ave., St. Louis, MO 63110. Tel.: 314-362-7243; Fax: 314-362-7058; E-mail: jgordon{at}pharmdec.wustl.edu.
1
The abbreviations used are: Nmt,
myristoyl-CoA:protein N-myristoyltransferase;
NMT1, S. cerevisiae myristoyl-CoA:protein N-myristoyltransferase gene; Nmt1p, the protein product of
NMT1; YPD, yeast/peptone/dextrose medium; SC, synthetic
complete medium; 5-FOA, 5-fluoro-orotic acid; ORF, open reading frame;
ts, temperature-sensitive; ITC, isothermal titration calorimetry; PCR,
polymerase chain reaction; PAGE, polyacrylamide gel
electrophoresis.
2
Further details concerning this gel shift assay
will be published elsewhere, including its validation using isogenic
strains with NMT1 or nmt1-451D plus various
combinations of wild type or null alleles of ARF1 and
ARF2 (Lodge, J., Jackson-Machelski, E., Devadas, B.,
Kishore, N., Freeman, S., McWherter, C., Sikorski, J., and Gordon, J.,
(1997) Microbiology, in press).
3
R. Bhatnagar, O. Schall, E. Jackson-Machelski,
J. Sikorski, G. Gokel, and J. Gordon, submitted for publication.
Acknowledgments
We are grateful to our colleagues Jenny
Lodge, Rajiv Bhatnagar, Eric Anderson, Balekudru Devadas, and James
Sikorski for many contributions to this study.
REFERENCES
-
Johnson, D. R., Bhatnagar, R. S., Knoll, L. J., and Gordon, J. I.
(1994)
Annu. Rev. Biochem.
63,
869-914
[CrossRef][Medline]
[Order article via Infotrieve]
-
Chow, M., and Moscufo, N.
(1993)
in
Lipid Modifications of Proteins (Schlesinger, M. J., ed), pp. 59-81, CRC Press, Inc., Boca Raton, FL
-
Bryant, M. L., Ratner, L., Duronio, R. J., Kishore, N. S., Devadas, B., Adams, S. P., and Gordon, J. I.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
2055-2059
[Abstract/Free Full Text]
-
Harper, D. R., Gilbert, R. L., Blunt, C. J., and McIlhinney, R. A. J.
(1993)
J. Gen. Virol.
74,
1181-1184
[Abstract/Free Full Text]
-
Lodge, J. K., Jackson-Machelski, E., Toffaletti, D. L., Perfect, J. R., and Gordon, J. I.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
12008-12012
[Abstract/Free Full Text]
-
Weinberg, R. A., McWherter, C. A., Freeman, S. K., Wood, D. C., Gordon, J. I., and Lee, S. C.
(1995)
Mol. Microbiol.
16,
241-250
[CrossRef][Medline]
[Order article via Infotrieve]
-
Devadas, B., Zupec, M. E., Freeman, S. K., Brown, D. L., Nagarajan, S., Sikorski, J. A., McWherter, C. A., Getman, D. P., and Gordon, J. I.
(1995)
J. Med. Chem.
38,
1837-1840
[CrossRef][Medline]
[Order article via Infotrieve]
-
Nadler, M. J. S., Harrison, M. L., Ashendel, C. L., Cassady, J. M., and Geahlen, R. L.
(1993)
Biochemistry
32,
9250-9255
[CrossRef][Medline]
[Order article via Infotrieve]
-
Felsted, R. L., Glover, C. J., and Hartman, K.
(1995)
J. Natl. Cancer Inst.
87,
1571-1573
[Free Full Text]
-
Magnuson, B. A., Raju, R. V., Moyana, T. N., and Sharma, R. K.
(1995)
J. Natl. Cancer Inst.
87,
1630-1635
[Abstract/Free Full Text]
-
Duronio, R. J., Towler, D. A., Heuckeroth, R. O., and Gordon, J. I.
(1989)
Science
243,
796-800
[Abstract/Free Full Text]
-
Duronio, R. J., Rudnick, D. A., Johnson, R. L., Johnson, D. R., and Gordon, J. I.
(1991)
J. Cell Biol.
113,
1313-1330
[Abstract/Free Full Text]
-
Knoll, L. J., Levy, M. A., Stahl, P. D., and Gordon, J. I.
(1992)
J. Biol. Chem.
267,
5366-5373
[Abstract/Free Full Text]
-
Rudnick, D. A., McWherter, C. A., Gokel, G. W., and Gordon, J. I.
(1993)
Adv. Enzymol.
67,
375-430
-
Rudnick, D. A., McWherter, C. A., Rocque, W. J., Lennon, P. J., Getman, D. P., and Gordon, J. I.
(1991)
J. Biol. Chem.
266,
9732-9739
[Abstract/Free Full Text]
-
Bhatnagar, R. S., Jackson-Machelski, E., McWherter, C. A., and Gordon, J. I.
(1994)
J. Biol. Chem.
269,
11045-11053
[Abstract/Free Full Text]
-
Duronio, R. J., Reed, S. I., and Gordon, J. I.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
4129-4133
[Abstract/Free Full Text]
-
Wiegand, R. C., Carr, C., Minnerly, J. C., Pauley, A. M., Carron, C. P., Langner, C. A., Duronio, R. J., and Gordon, J. I.
(1992)
J. Biol. Chem.
267,
8591-8598
[Abstract/Free Full Text]
-
Lodge, J. K., Johnson, R. L., Weinberg, R. A., and Gordon, J. I.
(1994)
J. Biol. Chem.
269,
2996-3009
[Abstract/Free Full Text]
-
Rudnick, D. A., Johnson, R. L., and Gordon, J. I.
(1992)
J. Biol. Chem.
267,
23852-23861
[Abstract/Free Full Text]
-
Meyer, K. H., and Schweizer, E.
(1974)
J. Bacteriol.
117,
345-350
[Abstract/Free Full Text]
-
Johnson, D. R., Cok, S. J., Feldmann, H., and Gordon, J. I.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
10158-10162
[Abstract/Free Full Text]
-
Stone, D. E., Cole, G. M., Lopes, M. B., Goebl, M., and Reed, S. I.
(1991)
Genes & Dev.
5,
1969-1981
[Abstract/Free Full Text]
-
Johnson, D. R., Duronio, R. J., Langner, C. A., Rudnick, D. A., and Gordon, J. I.
(1993)
J. Biol. Chem.
268,
483-494
[Abstract/Free Full Text]
-
Peseckis, S. M., and Resh, M. D.
(1994)
J. Biol. Chem.
269,
30888-30892
[Abstract/Free Full Text]
-
Muhlrad, D., Hunter, R., and Parker, R.
(1992)
Yeast
8,
79-82
[CrossRef][Medline]
[Order article via Infotrieve]
-
Ito, H., Fukuda, Y., Murata, K., and Kimura, A.
(1983)
J. Bacteriol.
153,
163-168
[Abstract/Free Full Text]
-
Hoffman, C. S., and Winston, F.
(1987)
Gene (Amst.)
57,
267-272
[CrossRef][Medline]
[Order article via Infotrieve]
-
Rose, M. D., Winston, F., and Hieter, P.
(1990)
Methods in Yeast Genetics: A Laboratory Course Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
-
Sikorski, R. S., and Hieter, P.
(1989)
Genetics
122,
19-27
[Abstract/Free Full Text]
-
Duronio, R. J., Gordon, J. I., and Boguski, M. S.
(1992)
Proteins Struct. Funct. Genet.
13,
41-56
[CrossRef][Medline]
[Order article via Infotrieve]
-
Laemmli, U. K.
(1970)
Nature
227,
680-685
[CrossRef][Medline]
[Order article via Infotrieve]
-
Rudnick, D. A., Duronio, R. J., and Gordon, J. I.
(1992)
in
Lipid Modification of Proteins: A Practical Approach (Hooper, N. M., and Turner, A. J., eds), pp. 37-61, IRL Press, Oxford
-
Kishore, N. S., Lu, T., Knoll, L. J., Katoh, A., Rudnick, D. A., Mehta, P. P., Devadas, B., Huhn, M., Atwood, J. L., Adams, S. P., Gokel, G. W., and Gordon, J. I.
(1991)
J. Biol. Chem.
266,
8835-8855
[Abstract/Free Full Text]
-
Hieter, P., Mann, C., Snyder, M., and Davis, R. W.
(1985)
Cell
40,
381-392
[CrossRef][Medline]
[Order article via Infotrieve]
-
Koshland, D., Kent, J. C., and Hartwell, L. H.
(1985)
Cell
40,
393-403
[CrossRef][Medline]
[Order article via Infotrieve]
-
Duronio, R. J., Jackson-Machelski, E., Heuckeroth, R. O., Olins, P. O., Devine, C. S., Yonemoto, W., Slice, L. W., Taylor, S. S., and Gordon, J. I.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
1506-1510
[Abstract/Free Full Text]
-
Devadas, B., Lu, T., Katoh, A., Kishore, N. S., Wade, A. C., Mehta, P. P., Rudnick, D. A., Bryant, M. L., Adams, S. P., Li, Q., Gokel, G. W., and Gordon, J. I.
(1992)
J. Biol. Chem.
267,
7224-7239
[Abstract/Free Full Text]
-
Lu, T., Li, Q., Katoh, A., Hernandez, J., Duffin, K., Jackson-Machelski, E., Knoll, L. J., Gokel, G. W., and Gordon, J. I.
(1994)
J. Biol. Chem.
269,
5346-5357
[Abstract/Free Full Text]
-
Paige, L. A., Zheng, G.-Q., DeFrees, S. A., Cassady, J. M., and Geahlen, R. L.
(1989)
J. Med. Chem.
32,
1665-1667
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lee, K. S., Hines, L. K., and Levin, D. E.
(1993)
Mol. Cell. Biol.
13,
5843-5853
[Abstract/Free Full Text]
-
Levin, D. E., and Bartlett-Heubusch, E.
(1992)
J. Cell Biol.
116,
1221-1229
[Abstract/Free Full Text]
-
Heuckeroth, R. O., and Gordon, J. I.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
5262-5266
[Abstract/Free Full Text]
-
Rudnick, D. A., Lu, T., Jackson-Machelski, E., Hernandez, J. C., Li, Q., Gokel, G. W., and Gordon, J. I.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
10507-10511
[Abstract/Free Full Text]
-
Cyert, M. S., and Thorner, J.
(1992)
Mol. Cell. Biol.
12,
3460-3469
[Abstract/Free Full Text]
-
Zhu, D., Cardenas, M. E., and Heitman, J.
(1995)
J. Biol. Chem.
270,
24831-24838
[Abstract/Free Full Text]
-
Stearns, T., Kahn, R. A., Botstein, D., and Hoyt, M. A.
(1990)
Mol. Cell Biol.
10,
6690-6699
[Abstract/Free Full Text]
-
Kahn, R. A., Clark, J., Rulka, C., Stearns, T., Zhang, C. J., Randazzo, P. A., Terui, T., and Cavenagh, M.
(1995)
J. Biol. Chem.
270,
143-150
[Abstract/Free Full Text]
-
Boman, A. L., and Kahn, R. A.
(1995)
Trends Biochem. Sci.
20,
147-150
[CrossRef][Medline]
[Order article via Infotrieve]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Wu, Y. Tao, M. Zhang, M. H. Howard, S. Gutteridge, and J. Ding
Crystal Structures of Saccharomyces cerevisiae N-Myristoyltransferase with Bound Myristoyl-CoA and Inhibitors Reveal the Functional Roles of the N-terminal Region
J. Biol. Chem.,
July 27, 2007;
282(30):
22185 - 22194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. P. Price, M. R. Menon, C. Panethymitaki, D. Goulding, P. G. McKean, and D. F. Smith
Myristoyl-CoA:Protein N-Myristoyltransferase, an Essential Enzyme and Potential Drug Target in Kinetoplastid Parasites
J. Biol. Chem.,
February 21, 2003;
278(9):
7206 - 7214.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. D. Shaw, C. Momany, and M. Momany
AspergillusnidulansswoF Encodes an N-Myristoyl Transferase
Eukaryot. Cell,
April 1, 2002;
1(2):
241 - 248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Qi, R. V. S. Rajala, W. Anderson, C. Jiang, K. Rozwadowski, G. Selvaraj, R. Sharma, and R. Datla
Molecular Cloning, Genomic Organization, and Biochemical Characterization of Myristoyl-CoA:Protein N-Myristoyltransferase from Arabidopsis thaliana
J. Biol. Chem.,
March 24, 2000;
275(13):
9673 - 9683.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ashrafi, T. A. Farazi, and J. I. Gordon
A Role for Saccharomyces cerevisiae Fatty Acid Activation Protein 4 in Regulating Protein N-Myristoylation during Entry into Stationary Phase
J. Biol. Chem.,
October 2, 1998;
273(40):
25864 - 25874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Stanley, V. Koronakis, and C. Hughes
Acylation of Escherichia coli Hemolysin: A Unique Protein Lipidation Mechanism Underlying Toxin Function
Microbiol. Mol. Biol. Rev.,
June 1, 1998;
62(2):
309 - 333.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Lodge, E. Jackson-Machelski, M. Higgins, C. A. McWherter, J. A. Sikorski, B. Devadas, and J. I. Gordon
Genetic and Biochemical Studies Establish That the Fungicidal Effect of a Fully Depeptidized Inhibitor of Cryptococcus neoformans Myristoyl-CoA:Protein N-Myristoyltransferase (Nmt) Is Nmt-dependent
J. Biol. Chem.,
May 15, 1998;
273(20):
12482 - 12491.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|